Hepatitis viruses in heamodialysis patients: an added insult to injury?

Kranthi Kosaraju, Sameer Singh Faujdar, Aashima Singh, Ravindra Prabhu, Kranthi Kosaraju, Sameer Singh Faujdar, Aashima Singh, Ravindra Prabhu

Abstract

Hepatitis B (HBV) and hepatitis C (HCV) viruses are the most important causes of chronic liver disease in patients with end stage renal disease on hemodialysis. The prevalence of hepatitis infection among hemodialysis patients is high and varies between countries and between dialysis units within a single country. This case-control study was undertaken to estimate the occurrence of HBV and HCV infections in patients undergoing hemodialysis in our tertiary care center. All patients receving hemodialysis at our centre with HCV or HBV infection were included in the study. The total number of patients admitted for hemodialysis during the study period was 1710. Among these, 26 patients were positive for HBV, 19 were positive for HCV, and 2 were positive for both HCV and HBV. Mean age of the infected cases in our study was 48.63 years. Mean duration of dialysis for infected cases was 4.8 years while that of the noninfected controls was 3.18 years. The mean dialysis interval was twice a week. Interventions to reduce the occurrence of these infections are of utmost need to reduce the risk of long-term complications among hemodialysis patients.

Figures

Figure 1
Figure 1
Hemoglobin values in cases infected with HBV and HCV.
Figure 2
Figure 2
Comparison of hemoglobin values among cases and controls (n = 45).
Figure 3
Figure 3
Risk factors among cases and controls.

References

    1. Abumwais JQ, Idris OF. Prevalence of hepatitis C, hepatitis B, and HIV infection among haemodialysis patients in Jenin District (Palestine) Iranian Journal of Virology. 2010;4(2):38–44.
    1. Bhaumik P, Debnath K. Prevalence of hepatitis B and C among haemodialysis patients of Tripura, India. Euroasian Journal of Hepato-Gastroenterology. 2012;2(1):10–13.
    1. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian Journal of Medical Microbiology. 2005;23(1):41–43.
    1. Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F, Ramezani A. Viral hepatitis and HIV infection in hemodialysis patients. Hepatitis Monthly. 2012;12(7):463–464.
    1. Otedo AEO, Mc’Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. South African Medical Journal. 2003;93(5):380–384.
    1. Busek SU, Babá EH, Tavares Filho HA, et al. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Memorias do Instituto Oswaldo Cruz. 2002;97(6):775–778.
    1. Agarwal SK, Dash SC, Irshad M. Hepatitis C virus infection during haemodialysis in India. Journal of Association of Physicians of India. 1999;47(12):1139–1143.
    1. Chowdhury A, Santra A, Chakravorty R, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. Journal of Gastroenterology and Hepatology. 2005;20(11):1712–1720.
    1. Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. Journal of the Indian Medical Association. 2001;99(4):194–199.
    1. Espinosa M, Martín-Malo A, Ojeda R, et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. American Journal of Kidney Diseases. 2004;43(4):685–689.
    1. Carneiro MAS, Teles SA, Dias MA, et al. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Memorias do Instituto Oswaldo Cruz. 2005;100(4):345–349.
    1. Kosaraju K, Padukone S, Bairy I. Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India. Tropical Doctor. 2011;41(3):170–171.
    1. Tourret J, Tostivint I, du Montcel ST, et al. Outcome and prognosis factors in HIV-infected haemodialysis patients. Clinical Journal of the American Society of Nephrology. 2006;1(6):1241–1247.
    1. Chandra M, Khaja MN, Hussain MM, et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology. 2004;47(6):374–376.
    1. Zahedi MJ, Moghaddam SD, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman Province, South-East Iran. Hepatitis Monthly. 2012;12(5):339–343.
    1. Covic A, Iancu L, Apetrei C, et al. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrology Dialysis Transplantation. 1999;14(1):40–45.
    1. Irish DN, Blake C, Christophers J, et al. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. Journal of Medical Virology. 1999;59(2):135–140.
    1. El-Ottol AEY, Elmanama AA, Ayesh BM. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virology Journal. 2010;7:p. 210.
    1. Sabry AAA, El-Dahshan KF, Mahmoud KM, El-Husseini AA. Effect of HCV infection on hematocrit and hemoglobin level in Egyptian hemodialysis patients. International Urology and Nephrology. 2009;41(1):189–193.
    1. Alsaran KA, Sabry AA, Alghareeb AH, Al Sadoon G. Effect of hepatitis C virus on hemoglobin and hematocrit levels in Saudi hemodialysis patients. Renal Failure. 2009;31(5):349–354.
    1. Lin YL, Lin CW, Lee CH, Lai IC, Chen HH, Chen TW. Chronic hepatitis ameliorates anaemia in haemodialysis patients. Nephrology. 2008;13(4):289–293.
    1. Radovic M, Jelkmann W, Djukanovic L, Ostric V. Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. Journal of Interferon and Cytokine Research. 1999;19(4):369–373.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel